Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes

Update Il y a 4 ans
Reference: NCT00787384

Woman and Man

  • | Country :
  • Italy
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The study was performed to assess: 1) clinical activity of Imatinib in patients with HES, CEL and CIH; 2) correlation between Imatinib activity and specific disease subtype; 3) long-term outcome of HES, CEL and CIH patients treated with Imatinib; 4) safety and tolerability of Imatinib administration.


Inclusion criteria

  • Hypereosinophilic Syndrome ,Chronic Eosinophilic Leukemia ,Chronic Idiopathic Hypereosinophilia

Links